Original Research
Published on 15 Nov 2024
β-cryptoxanthin suppresses oxidative stress via activation of the Nrf2/HO-1 signaling pathway in diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1480629
Type at least 3 characters
561 articles
Articles
Systematic Review
Accepted on 14 Nov 2024
Efficacy and safety of glucocorticoid combined with cyclophosphamide therapy on membranous nephropathy: a systematic review and metaanalysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1480638
Review
Published on 14 Nov 2024
Roles of macrophages in lupus nephritis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477708
Original Research
Accepted on 11 Nov 2024
Yishen Paidu Pills Attenuates 5/6 Nephrectomy Induced Kidney Disease via Inhibiting the PI3K/AKT/mTOR Signaling Pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1510098
Original Research
Accepted on 11 Nov 2024
Calcium sensing receptor regulate claudin-14 via PKA-STAT3 pathway in rat model of nephrolithiasis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477122
Correction
Published on 05 Nov 2024
Corrigendum: Association between amoxicillin administration and outcomes in critically ill patients with acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1468612
Systematic Review
Accepted on 29 Oct 2024
Focus on Podocytes: Diabetic Kidney Disease and Renal Fibrosis -A Global Bibliometric Analysis (2000-2024)
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1454586
Original Research
Published on 28 Oct 2024
Effects of Abelmoschus manihot (L.) and its combination with irbesartan in the treatment of diabetic nephropathy via the gut–kidney axis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1424968
- 220 views
Brief Research Report
Published on 24 Oct 2024
DREADD agonist compound 21 causes acute diuresis in wild-type mice
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1471059
- 212 views
Original Research
Published on 22 Oct 2024
Sphagnum cuspidatulum extract prevents acute kidney injury induced by high-fat diet and streptozotocin via alleviation of oxidative stress and apoptosis in pre-diabetic rats
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1464463
- 378 views
Review
Accepted on 21 Oct 2024
Advances in the study of key cells and signaling pathways in renal fibrosis and the interventional role of Chinese medicines
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1403227
Original Research
Published on 18 Oct 2024
Comparison of sGC activator and sGC stimulator in 5/6 nephrectomized rats on high-salt-diet
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1480186
- 370 views
Original Research
Published on 07 Oct 2024
SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1415879
- 1,052 views
Review
Published on 04 Oct 2024
Exploring potential targets for natural product therapy of DN: the role of SUMOylation
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1432724
- 756 views
Original Research
Published on 02 Oct 2024
Spatiotemporal delivery of multiple components of rhubarb-astragalus formula for the sysnergistic treatment of renal fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1456721
- 681 views
Original Research
Published on 27 Sep 2024
Anisodamine (654-1/654-2) ameliorates septic kidney injury in rats by inhibiting inflammation and apoptosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1421551
- 500 views